Gábor T Kovács (Gábor Kovács)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

International journal of molecular sciences

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Carolin Christ, Zsombor Ocskay, Gábor T Kovács, Zoltán Jakus
Characterization of Atherosclerotic Mice Reveals a Sex-Dependent Susceptibility to Plaque Calcification but No Major Changes in the Lymphatics in the Arterial Wall. International journal of molecular sciences 25 (7) (2024)
Carolin Christ, Zsombor Ocskay, Gábor T Kovács, Zoltán Jakus
Characterization of Atherosclerotic Mice Reveals a Sex-Dependent Susceptibility to Plaque Calcification but No Major Changes in the Lymphatics in the Arterial Wall. International journal of molecular sciences 25 (7) (2024)
Carolin Christ, Zsombor Ocskay, Gábor T Kovács, Zoltán Jakus
Characterization of Atherosclerotic Mice Reveals a Sex-Dependent Susceptibility to Plaque Calcification but No Major Changes in the Lymphatics in the Arterial Wall. International journal of molecular sciences 25 (7) (2024)
Anne Sofie Borg Hammer, Kristian Løvvik Juul-Dam, Julie Damgaard Sandahl, Jonas Abrahamsson, Malgorzata Czogala, Emmanuelle Delabesse, Iren Haltrich, Kirsi Jahnukainen, E Anders Kolb, Gábor T Kovács, Guy Leverger, Franco Locatelli, Riccardo Masetti, Ulrika Norén-Nyström, Susana Raimondi, Mareike Rasche, Dirk Reinhardt, Tomohiko Taki, Masanori Yoshida, Bernward Zeller, Henrik Hasle, Eigil Kjeldsen
Hypodiploidy has Unfavorable Impact on Survival in Pediatric Acute Myeloid Leukemia:An I-BFM Study Group collaboration. Blood advances (2022)
Dániel Szőke, Gábor T Kovács, Éva Kemecsei, Laszlo Balint, Kitti Szoták-Ajtay, Petra Aradi, Andrea Styevkóné Dinnyés, Barbara L Mui, Ying K Tam, Thomas D Madden, Katalin Karikó, Raghu P Kataru, Michael J Hope, Drew Weissman, Babak J Mehrara, Norbert Pardi, Zoltán Jakus
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema. Nature communications 12 (1) (2021)